MBRX.NASDAQMoleculin Biotech, INC

Form 4: Moleculin Biotech CFO Jonathan P. Foster Reports Stock Transactions

Sentiment:

SEC Form 4 Filing

📋All filings for Moleculin Biotech, INC
🔒Login to Follow

Jonathan P. Foster, CFO of Moleculin Biotech, reports the vesting and subsequent disposal of restricted stock units to cover tax obligations.

Summary

  • On June 22, 2024, Jonathan P. Foster, the CFO of Moleculin Biotech, reported transactions involving the company's common stock.
  • Foster acquired 4,329 shares of common stock through the vesting of restricted stock units (RSUs).
  • Simultaneously, Foster disposed of 4,329 shares related to the vesting of restricted stock units.
  • Additionally, 1,053 shares were disposed of to cover tax obligations at a price of $3.74 per share.
  • Following these transactions, Foster directly owns 11,363 shares of Moleculin Biotech.
  • Foster also holds 64,837 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about ownership changes.

Industry Context

Form 4 filings are standard practice for company insiders to report changes in their beneficial ownership of company stock, ensuring transparency and compliance with SEC regulations.

Key Dates

DateDescription
06/22/2023Reporting person was granted 17,313 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
06/22/2024Date of stock transactions: vesting of RSUs and disposal for tax obligations.
06/25/2024Date of signature on the Form 4 filing.

Keywords

Moleculin Biotech, MBRX, Jonathan P. Foster, CFO, Form 4, Stock Transactions, Restricted Stock Units, RSU, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.